HGEN - GME AMRS CLII and HGEN among premarket gainers

Adamis Pharmaceuticals (ADMP) +66% as its epinephrine products added to Walgreens club.Climate Change Crisis Real Impact I Acquisition Corporation (CLII) +48% as EV fast charging company EVgo to go public via SPAC.SCYNEXIS (SCYX) +36%.Humanigen (HGEN) +20% on expanding partnership with U.S. government for development of lenzilumab in COVID-19.iBio (IBIO) +22%.Aemetis (AMTX) +20% as its biofuels production process has received a $16.8M of solar energy and other energy efficiency grants.Fluidigm Corporation (FLDM) +25% on receiving CE-IVD mark for its Advanta COVID-19 test.ServiceSource International (SREV) +7%.NanoVibronix (NAOV) +27%.Atossa Therapeutics (ATOS) +11%.ThermoGenesis Holdings (THMO) +10%.electroCore (ECOR) +9%.CLPS Incorporation (CLPS) +13% after announcing strategic investment in Shanghai Shier Information Technology.BioCryst Pharmaceuticals (BCRX) +8% as its hereditary angioedema med OK'd in Japan.Boqii Holding Limited (BQ) +8%.ProQR Therapeutics N.V. (PRQR) +8%.Amyris (AMRS) +8% on acquiring Terasana Brand.Tengasco (TGC) +4%.Vascular Biogenics (VBLT) +4%.GameStop Corp. (GME) +5%.Conformis (CFMS) +5% on entering development and supply agreement with SITES Medical.

For further details see:

GME, AMRS, CLII and HGEN among premarket gainers